Skip to main content
. 2021 Feb 28;33(1):53–60. doi: 10.21147/j.issn.1000-9604.2021.01.06

1. Clinical characteristics of study patients (N=46).

Characteristics n (%)
Age (year)
 70−79 31 (67.4)
 80−90 15 (32.6)
Gender
 Male 33 (71.7)
 Female 13 (28.3)
Karnofsky performance score
 70−80 6 (13.0)
 90−100 40 (87.0)
Weight loss (last 6 months)
 <5% 30 (65.2)
 ≥5% 16 (34.8)
Histology
 Adenocarcinoma 1 (2.2)
 Squamous cell carcinoma 45 (97.8)
 Primary tumor location
 Upper thoracic segment 13 (28.3)
 Middle thoracic segment 23 (50.0)
 Lower thoracic segment 10 (21.7)
T stage
 T1 1 (2.2)
 T2 3 (6.5)
 T3 25 (54.3)
 T4 17 (37.0)
N stage
 N0 9 (19.6)
 N1 37 (80.4)
M stage
 M0 38 (82.6)
 M1a 8 (17.4)
Clinical stage
 I 10 (21.7)
 II 28 (60.9)
 III 8 (17.4)
Length of primary tumor (cm)
 <5 12 (26.1)
 ≥5 34 (73.9)
Charlson score
 0 (group A) 34 (73.9)
 ≥1 (group B) 12 (26.1)
Dysphagia grade
 Normal 9 (19.6)
 Soft 15 (32.6)
 Semifluid 9 (19.6)
 Fluid 13 (28.3)